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Heterogeneous biocatalysis in the
generation of thrombin
H. C. Hemker and R. F. A. ZwaaI
The sequence of Conversions of proenzyme into enzyme, whichleads to the formation
of thrombin in blood as soon as it leaves normal circulation, has recently been subject
to extensive investigation. The plasma proteins involved in this process have been
purified and the prímary structure of most of them is known.
The sequence of proteolytical cleavages
that eventually forms thrombin is well
documented (for reviews, see Reti 1,2).
We will discuss a peculiar feature of the
blood coagulation reaction sequence. viz.
the occurrence of proteoiytic enzymes in a
complex with phospholipids and an'accee
sory protein' which allows the enzvmes to
act with much increased efficiency.
The activation of prothrombin mav serve
as a Íirst example. Prothrombin (see Fig. I )
is a 72,500 mol. wt protein, the C-terminal
part of which yields thrombin when cleaved
at two different sites. This cleava-se is
brought about by a serine protease called
activatedfactor X (F.X"). The velocity of
this reaction can be enhanced up to
100.00tt-fold by the addition of a plasma
protein called factor V^ and a suitable
phospholipid surface. Factor Xu and factor
Vu adsorb at the phospholipid-water inter-
face to form a complex which converts pro
thrombin (F.II) into thrombin (Fig. 2a). A
second example concerns the activation of
factor X. The unactivated factor X which
occurs as a proenzyme in plasma. is con-
verted into an active protease by a complex
consisting of the protease factor IX"
together with the accessory protein factor
VIII' adsorbed at a phospholipid surtace
(Fie.2b) .
We investigated the mechanisms by
which the phospholipids and the accessory
protein, neither of which have any enzy-
matic action by themselves, influence the
activity of the proteolytic enzymes. lt is not
our intention to give a complete review of
blood coagulation biochemistry and conse-
quently several important items will not be
discussed such as:
(i) the way in which
vated;
(ii) the activation of
factor IX is acti-
factor X by tissue
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thromboplastin and factor VII";
(iii) the fact that the accessory proteins
(F.V., F.VIII) have to be activated by
thrombin in order to be able to participate in
the reaction.
We will focus our attention to the two
complexes shown in Fig. 2, not only
because they can serve as good examples of
heterogeneous biocatalysis but also because
they show a mechanism.that may be of
much more general importance than in the
coagulation of blood alone.
Two relatively recent developments
made it possible to study these complexes
in some detail: first, it is possible to purify
the blood coagulation factors. giving prep
arations that contain no detectable con-
taminants as judged by physical, chemical
or functional analyses'. Elementary though
this may seem, most of the early research
was carried out with impure preparations.
The coagulation factors II, VII, IX and X
have extensive homologies and copurify
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Fig. I . Proteolytic activation of prothrombin
under a large variety of conditions. A sec-
ond major step forward was the introduc-
tion of chromogenic substrates. These are
tri- or tetrapeptides, usually blocked at the
N-terminal end and linked to a
p-nitroanilide group at the C-terminal.
Specific combinations of amino acids make
them especially vulnerable to certain serine
amidases that arise during blood coagula-
tion. For example, H-D-Phe-PipArg-pNA
e.g. is specifically split by thrombin (F.II")
whereas BaIIe-Glu-Gly-Arg-pNA is
specific for activated factor X (F.X") (Refs
4 ,5 ) .
With purified clotting factors and
chromogenic substrates the experimental
set up sketched out in Fig. 3 made it possible
to investigate four details of the reac-
t ionn'5 'e.
(a) By varying the components of the
enzyme complex the stoichiometry of
enzyme (i.e. factor IXu or factor X^),
accessory protein (i.e. factor VIII" or
factor V,) and phospholipid surface
could be determined
(b) By varying the substrate concentra-
tion, the K. and k.ur of the activating
enzyme complex in its different forms
could be determined
(c) By varying the phospholipid composi-
tion, the optimal phospholipid
requirement for the interaction could
be investigated.
(d) By substituting blood platelets (throm-
bocytes) for phospholipids, it was
possible to discover the conditions
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under which these cells make pro
coagulant phospholipids.
We will discuss the results in terms of
prothÍombinase and only divert our atten-
tion to the factor X-activating enzyme
where this shows. special features. In gen-
eral. the results hoidzutatis mutandis for
both enzyme complexes (see Table I).
Factor Xu in free solution (that is in the
absence of phospholipids) can activate
prothombin by its own, but only very
slowly. Addition of factor Va cêus€S àn
increase in the turnover number ofthis reac-
tion but does not influence the K. to any
appreciabie xtent. Factor V, and Factor X"
ïorm a I :1'stoichiometric omplex with a
dissociat ionconstantof  3 x  l0  "M. When.
on the other hand, only phospholipids are
added to factor X, (that is in the absence of
factor V,) the turnover number of pro.
thrombin activation hardly changes, but the
K- drops markedly.. For this to occur it is
necessary that both the enzyme and the sub..
strate bind to the phospholipid surface. This
binding is mediated by 7-carboxy glutamic
acid residues in the N-terminal part of both
proteins..These r sidues are produced from
normal glutamic acid residues by vitamin
K-dependent carboxylation. ln vitamin K
deficiency this carboxylation does not take
place and uncarboxylated clotting factors
can be isolated from the plasma. These
molecules are perfectly capable of forming
normal active sites upon activation but they
do not bind to phospholipids and therefore
can be used to investigate the importance of
this bindingl7'8.
When factor V" and 
'phospholipid 
are
both present, k.nr increases with a con-
comitant decrease in K.. In this way the
catalytic efficiency of the reaction can be
increased up to 105 times for prothrombin-
ase and 1.5 x 107 times for the factor X
activating enzyme complex.
ln phenomenological teÍïns. a decrease
of K. can be described as an increase in
local substrate concentration. In mechanis-
tic terms, it means that more enzyme-sub-
strate encounters occur that lead to a prG-
ductive complex. Two types of mechan-
i,sms could produce this effect.
(l) Mechanisms that cause encounters
between enzyme and substrate to be
more productive, i.e. a decrease in the
dissociation constant of the enzyme
substrate complex. This might be
caused by a conformational change in
the enzyme brought about by adsorp
tion on to the phospholipid surface.
(2) Mechanisms that cause encounters
between enzyme and substrate to be
more frequent. In this case, the number
of productive encounters could
increase either because of the high
local concentration of both molecules
Fig. 2. Prothrombinase and the factor X activating complex
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Fig. 3. Method for measuring the rate of thrombinformation. (The rate of Factor X activation is measured in an
analogous set up. )
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TABLE I,
Kinetic parameters of prothrombin and tàctor X activation{ "
/n'ar (g.mol llq min 'g.mole Xe)
0 .68
L- r
l 9 l 9
/n 'o* (p.mol  Xl  min 'prmole lXa ' )
0 . 0 1
0.002-5
500
mobility in the plane of adsorption.
Another possibility is that sufficient fluidity
is a necessary condition for the binding of
factor V..
It is known that mixtures of phos
pholipids act better in coagulation than pure
phospholipids. This was also confirmed
with the system described above. lt is inter-
esting to note, however, that the optimal
ratio of PS to PC is diÍïerent fbr the complete
prothrombinase complex as compared to
the factor X activating complex. This is
especially important in the l ight of the
results obtained when blood platelets are
used as a source of phospholipid.
Zwaal and crlworkerst' showed that
phospholipids are asymmetri lally distrt-
buted between the inner and the outer leaf-
lets of platelet and red cell plasma mem-
branes. This explains why the inner Íàce is
strongly procoagulant and the outside is not
and, thereÍbre. ruptured cells increase pro.
coagulant activity. 
' fo 
our surprise, how-
ever, we could show that platelets. unlike
other cells, can be triggered to make pro-
coagulant phospholipids available without
rupture of the cell. This means that the
intact cell can present part of its inner mem-
brane face to the outside. and suggests a
fl ipÍ1op mechanism exchanging the inner
nM X" /m i r {
P rot hro r n h in oc t iv akt r
Xo.  Ca'
Xa.  Ca'  .  PL (7.5 prr)
X".  Ca'  .  PL (7.5 g.u) .  V,+
Fator X activator
IXa. Ca'
IXa. Ca' . PL (10 pt'r)
IXe.  Ca' !  .  PL (101: .v)Vl l le
Km (prrt)
84
0.06
0 . 2 1
K'" (ptlrt)
l 8 l
0.06
0.063
at the lipid surface (assuming a sufï-
cient lateral mobility of the molecules)
and/or because of a higher number of
sterically favourable encounters when
the molecules become oriented at the
surÍ-ace.
At the moment, no clearcut decision
between these models can be made,
although calculations of k,o'f K^ in the first
model lead to numbers as high as 3.3 x 10e
s 1 M-1 which would indicate a catalytic
efficiency higher than other serine prc.
teases and equal to the most efficient
enzyme known (i.e. crotonase, 2.8 x 108
s-t M-t). In the second model, k,uf K^ of
the surface bound species would be about
4.6 Y 10' s t v 1 which seems more
realistic.
Two interesting observations hed some
light upon the possible action of factor Vu in
increasing k*'. First, in the absence of fac-
tor Va, only the first cleavage of prothrom-
bin takes place (see Fig. l). The intermed-
iate product, that is one chain inactive
thrombin (prethrombin 2), is dissociated
from the enzyme. In the presence of factor
Vu however, prethrombin 2 is cleaved
immediately after its formation and twG
chain thrombin is the only product found
under these conditionsn. Secondly, the
chromogenic substrate split by factor Xu
competitively inhibits the conversion of
factor II because it occupies the active site
of ,factor X", as would be expected. In the
absence of factor Vu however, prothrombin
at concentrations as high as l0 x K-, quite
unexpectedly does not inhibit the conveÍ-
sion of the small molecular weight sub-
strate. At this substrate concentration, more
than 90o/o of the enzyme is bound to prG
thrombin, yet it appears that the large major-
ity of its active sites are free. We therefore
surmise that factor Vo orients the vulnerable
sites of the large molecular substrate to the
active sites of the activating enzyme, and
keeps the intermediate product near the
enzyme so that its second vulnerable site is
cleaved immediately after the first.
Investigations of the effect of the phos
pholipid composition on the reaction con-
firmed the well-known observations that a
net negative charge ofthe phospholipids is
a prerequisite for their activity. It also
appears that the phospholipids must be
above their transition temperature to act as
procoagulants. This was found by compar-
ing mixed vesicles of synthetic phos
phatidylserine (PS) and phosphatidyl-
choline (PC) with different fatty acid com-
positions. The activity of the mixtures
below their transition point could be mar-
kedly enhanced by adding cholesterolÍ'. a
procedure which induces a more t'luid state
of the bilayer.
Why membrane fluidity is important can-
not yet be explained with certainty. lt can
be argued, however, that the lateral mobil-
ity of proteins bound to fluid lipid surfàces
will be much higher than proteins bound to
lipids in the gel state. At least one of the
models proposed to explain the action ot
phospholipids (no. 2) requires lateral
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Fig. 4. Efièct of activated platelets on prothrombin and factor X activation. (Taken from Zwaal and Hemker,
Haemostasis (1982) 11, l2*39.)
2 0
1 0
I-o_o
2 52 01 51 0
4
leaflet phospholipids for those in rhe ourer
leaflet This was demonstrated by the
occuÍrence ofprocoagulant activity and by
analysis of the phospholipids present in the
outer leaflet after activation of the
plateletl l.
The trigger to ihduce this behaviour is the
simultaneous presence of a small amount of
tbrombrnand collagen. These are precisely
the conditions present at the site of an
injury. The collagen beneath the normal
endothelial cells becomes exposed and the
tissue thromboplastin released by wounded
cells (of almost any type) wil l rapidly lead
to the Íbrmation of small amounts of
thrombin by a pathway not discussed here.
In this way, platelets adhering at the site of
an injury become powerful sources of
thrombin-forming activity. ' l 'he conse-
quence of this haemostatic mechanism is
self evident but this process presumably
also plays a role in thrombus fbrmation that
might occur at atherosclerotic lesions.
The presentation ofphospholipids by the
intact triggered blood platelet should not be
confused with the so-called'platelet release
reaction' as it indeed repeat;dly has been.
In this reaction, the platelet secretes ADP,
serotonin, coagulation factor V, Ca2' and
many other substances. It is emphasized
that thrombin alone causes the release reac-
tion but this does not lead to increased
eiposure of procoagulant phospholipids.
Only thrombin together with collagen pro-
duces this effect. Another point of interest
is the sequential generation of a phos-
pholipid surface suitable for the activation
of factor X and prothrombin. As factor
X-activating complex produces active fac-
tor X, which then acts on prothrombin to
produce the clotting enzyme thrombin, fac-
tor X activation must precede prothrombin-
ase activity. lt is indeed surprising to
observe that activation of platelets by col-
lagen plus thrombin first leads to a lipid
composition suitable as a surface for the
generation of factor X, and only later deliv-
ers the optimal phospholipid surface for
prothombinase (Fig. 4).
Apart from its evident interest for the
understanding of haemostasis and throm-
bosis, biochemical research in the field of
blood coagulation also ofÏers the opportun-
ity to study the interaction of proteins at
phospholipid-water boundaries. These pro
cesses are of fundamental interest because
of the many important biochemical reac-
tions occurring at cell or organelle mem-
TIBS -October 1982
branes. Until now. the understanding of
biochemical processes occurring in fiee
solution Íàr exceeds that of processes at
intertàces.
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